Research Article

Coinfections with Respiratory Pathogens among COVID-19 Patients in Korea

Table 1

Study subjects (N = 342) with COVID-19 coinfected with respiratory pathogens.

Patients coinfected with respiratory pathogensNo. of patients coinfected (%)M : FMean age (SEM)Region of residency (no. of patients)Classification of the coinfections by types of specimen (N = 25)
No. (%) of SARS-CoV-2 positive in
NPS/OPSSputumBoth

Virus (N = 27, 7.9%)Flu A3 (0.9)1 : 230.3 (14.7)KP (3)21
RSV6 (1.8)1 : 537.5 (8.3)KP (6)222
Adv2 (0.6)2 : 029.0 (8.0)KP (1),11
KG (1)
MPV3 (0.9)1 : 240.3 (8.0)KP (3)3
HRV6 (1.8)2 : 437.2 (6.4)KP (4),33
Seoul (1)
KG (1)
Non-SARS-CoV-2 coronavirus5 (1.5)3 : 239.8 (6.9)KP (5)14
MPV/Adv1 (0.3)0 : 153KP (1)1
HRV/HBoV1 (0.3)0 : 125KP (1)1

Bacteria (N = 3, 0.9%)M. pneumoniae3 (0.9)2 : 132.0 (6.0)KP (3)3
Total (N = 30, 8.8%)3012 : 1836.4 (2.9)8 (26.7)4 (13.3)18 (60.0)

COVID-19: coronavirus disease 2019; Flu A: influenza A; RSV: respiratory syncytial virus; Adv: adenovirus; MPV: metapneumovirus; HRV: rhinovirus; Non-SARS-CoV-2 coronavirus: coronaviruses 229E, NL63, and OC43; M. pneumoniae: Mycoplasma pneumoniae; KP: Kyungpook Province; KG: Kyunggi Province; SEM: standard error of mean.NPS/OPS specimens were submitted only without sputum.